Ankit Mahadevia is the CEO of Spero Therapeutics and a member of the Board of Directors. He was formerly a Venture Partner in the life sciences group at Atlas Venture, located in Cambridge, MA.
Read More
Jonathan Rigby is an experienced CEO with three decades of experience creating value and opportunities for companies in the pharmaceutical, biotech and drug delivery technology industry. He currently serves as the CEO of Revolo Biotherapeutics, a biotechnology company setting out to revolutionize the treatment for autoimmune and allergic diseases, through the development of therapies that reset the immune system to achieve superior long-term disease remission.
Read More
Balkrishan (Simba) Gill, Ph.D. has served as our President, Chief Executive Officer and a member of our Board of Directors since September 2015. Dr. Gill also has served on the board of directors of Realm Therapeutics PLC since 2016, and as a Venture Partner at Flagship Pioneering, a life sciences innovation enterprise, since 2015.
Read More
Yizhen is passionate about investing in and working with persevering entrepreneurs who want to change the world, especially in healthcare and biotech. Yizhen focuses on early stage investments in frontier technologies applied to healthcare and life sciences, with interests across artificial intelligence, engineering, robotics/automation, and new biology.
Read More
Dr. Bexon brings to Vyriad more than 20 years of management experience in clinical development of biopharmaceuticals, including management of multi-site clinical trials and FDA approval of lead assets. Prior to joining Vyriad, Dr. Bexon founded Bexon Clinical Consulting, which provides clinical development support to the pharma and biotech industries.
Read More
Martin (Marty) is a cofounder and chief executive officer of Meissa Vaccines. Prior to cofounding Meissa, Marty was an Associate Professor at Emory University and director of the Emory Children’s Center for Childhood Infections and Vaccines (CCIV).
Read More
Dr. Miller is a Founder and the Chief Operating Officer of Karuna Therapeutics. Dr. Miller is the lead inventor of Karuna’s KarXT platform and served as CEO of Karuna from 2016-2018.
Read More
Sam Mazin, Ph.D., co-founded RefleXion Medical in 2009, where he is the inventor of the company’s core technology. Thorsten Melcher, Ph.D., joined RefleXion in July 2019 as chief business officer with over 25 years of experience in biotechnology and pharmaceutical business development.
Read More
Heather Wolff joined Decibel in February 2018 as the head of clinical development operations for Decibel Therapeutics.
Read More
Rachel is a co-founder of Caribou Biosciences and has been President and CEO since its inception in 2011.
Read More
Dr. Ragan has been X4’s President and Chief Executive Officer and a member of the X4 Board of Directors since July 2014. She has more than 18 years of experience building companies in the biotechnology industry.
Read More
Joseph Hernandez is an established leader in biotech entrepreneurship and early-stage technology development. With a strong background in biology, epidemiology, molecular genetics, marketing, and finance, Mr. Hernandez has successfully founded or led six entrepreneurial companies, including Blue Water Vaccines.
Read More